When to Order Imaging for Clinically Suspected Adnexal Mass, No Acute Symptoms: ACR Appropriateness Decoded

An adnexal mass is a common incidental finding or physical exam discovery. For the clinician evaluating a patient without acute symptoms like severe pain, fever, or hemodynamic instability, the next step is crucial. The primary goal is to characterize the mass, assess the likelihood of malignancy, and guide further management, all while avoiding unnecessary radiation or invasive procedures. The American College of Radiology (ACR) Appropriateness Criteria provide an evidence-based framework for selecting the best initial and follow-up imaging studies. This guide distills those recommendations for busy clinicians.

What Does ACR Clinically Suspected Adnexal Mass, No Acute Symptoms Cover?

This ACR topic provides imaging guidance for adult and pregnant females with a suspected adnexal mass discovered on clinical examination or as an incidental finding on imaging performed for other reasons. The key qualifier is the absence of acute symptoms. This guideline is intended for initial evaluation, follow-up of likely benign or indeterminate masses, and further characterization of masses suspicious for malignancy on initial ultrasound.

These recommendations do not apply to patients presenting with acute pelvic pain, suspected ovarian torsion, ectopic pregnancy, or pelvic inflammatory disease. Those scenarios represent distinct clinical emergencies with their own dedicated imaging algorithms. This guideline also does not cover imaging for definitive cancer staging after a diagnosis has been established, which often involves more extensive cross-sectional imaging of the chest, abdomen, and pelvis.

What Imaging Should I Order for Clinically Suspected Adnexal Mass, No Acute Symptoms? Recommendations by Clinical Scenario

The choice of imaging depends on the initial clinical presentation, the patient’s menopausal and pregnancy status, and the findings of prior imaging studies.

For the initial imaging of an adult female (premenopausal or postmenopausal) with a clinically suspected adnexal mass and no acute symptoms, ultrasound is the undisputed first-line modality. The ACR rates US pelvis transabdominal and US pelvis transvaginal, as well as Duplex Doppler US, as Usually appropriate. Ultrasound is non-ionizing, widely available, and highly effective at characterizing the morphology of adnexal structures, distinguishing simple cysts from complex or solid masses.

For follow-up imaging of an adnexal mass considered likely benign in either premenopausal or postmenopausal women, ultrasound remains the preferred modality. The ACR again rates US pelvis transvaginal and other ultrasound techniques as Usually appropriate. This allows for safe, serial monitoring of the mass for changes in size or character without exposing the patient to radiation.

When an initial pelvic ultrasound is indeterminate, the next step is problem-solving with a more advanced modality. For an adult female with an indeterminate adnexal mass on US, MRI pelvis without and with IV contrast is rated as Usually appropriate for further characterization. MRI offers superior soft-tissue contrast, which can help differentiate various tissue types within the mass (e.g., fat in a dermoid, blood products in an endometrioma) and better assess features concerning for malignancy.

Similarly, for follow-up of an indeterminate mass, both ultrasound and MRI play a role. For a premenopausal or postmenopausal patient with an indeterminate mass, follow-up with US pelvis transvaginal or MRI pelvis without and with IV contrast are both considered Usually appropriate.

If the initial ultrasound is highly suspicious for malignancy, MRI pelvis without and with IV contrast is Usually appropriate to better characterize the lesion and assess for local invasion before surgical planning. In this specific scenario, CT pelvis without and with IV contrast is rated May be appropriate (Disagreement), reflecting its potential role in staging for metastatic disease, though MRI is generally preferred for local characterization.

In pregnant patients, the guidelines prioritize fetal safety. For initial imaging, pelvic ultrasound is Usually appropriate. If the ultrasound is indeterminate, MRI pelvis without IV contrast is Usually appropriate for further characterization. The use of gadolinium-based contrast agents (MRI with contrast) is Usually not appropriate during pregnancy unless the potential benefits are deemed to outweigh the potential risks to the fetus.

ACR Imaging Recommendations Table

Adult vs. Pediatric Clinically Suspected Adnexal Mass, No Acute Symptoms Imaging: Radiation Dose Tradeoffs

For the evaluation of an adnexal mass, the recommended imaging pathways for both adults and children strongly favor non-ionizing modalities. Ultrasound and MRI, which carry no radiation dose, are the cornerstones of diagnosis and follow-up. This inherently aligns with the As Low As Reasonably Achievable (ALARA) principle, which is especially critical in pediatric patients who have a longer lifetime to manifest potential risks from radiation exposure.

While CT is rated ‘Usually not appropriate’ for most adnexal mass scenarios, it’s important to note the different relative radiation level (RRL) designations between adults and children. For instance, a CT pelvis with IV contrast is rated ☢ ☢ ☢ (1-10 mSv) for an adult but carries a higher RRL of ☢ ☢ ☢ ☢ (3-10 mSv) for a pediatric patient. This reflects the increased radiosensitivity of developing tissues. These differences underscore why CT should be avoided for this clinical indication, particularly in younger patients, unless there are compelling reasons where the benefits of CT decisively outweigh the risks and alternative non-ionizing studies are unavailable or contraindicated.

Imaging Protocol Details for Clinically Suspected Adnexal Mass, No Acute Symptoms

Once you’ve decided on the right study, the specific imaging protocol is essential for diagnostic quality. Our protocol guides cover key considerations for technique, contrast administration, and interpretation for many of the studies discussed in these ACR criteria. For detailed guidance on performing CT scans when they are indicated for other reasons, see our protocol library.

• CT Chest/Abdomen/Pelvis with IV Contrast
• CT Abdomen/Pelvis Without Contrast (Renal Stone)

Tools to Help You Order the Right Study

Navigating imaging guidelines can be complex. GigHz provides several tools designed to support clinical decision-making and streamline the ordering process.

The Imaging Appropriateness Selector tool allows you to quickly search the full ACR guidelines for thousands of clinical variants beyond adnexal masses, ensuring you are always referencing the latest evidence-based recommendations.

Our Imaging Protocol Library provides detailed, step-by-step protocols for a wide range of CT, MRI, and ultrasound examinations. This resource is invaluable for ensuring the study you order is technically optimized to answer the specific clinical question.

For discussions about radiation exposure with patients, the Radiation Dose Calculator helps estimate cumulative effective dose from various imaging studies. This can be a useful aid for shared decision-making and for tracking a patient’s total radiation exposure over time.

Frequently Asked Questions

Why is ultrasound the first-line imaging test for a suspected adnexal mass?

Ultrasound is the ideal initial imaging modality because it is non-invasive, does not use ionizing radiation, is widely available, relatively inexpensive, and provides excellent real-time evaluation of pelvic anatomy. Transvaginal ultrasound, in particular, offers high-resolution images of the ovaries and uterus, allowing for detailed characterization of a mass’s size, shape, and internal features (e.g., cystic, solid, complex).

When should I order an MRI instead of a follow-up ultrasound?

An MRI is the primary problem-solving tool when an ultrasound is indeterminate. If the ultrasound cannot confidently distinguish a benign from a potentially malignant lesion, MRI’s superior soft-tissue contrast can clarify the diagnosis. It is particularly useful for identifying fat within a teratoma (dermoid cyst), characterizing blood products in an endometrioma, or assessing complex solid components that are suspicious for malignancy.

Is CT ever appropriate for evaluating an adnexal mass?

For the initial characterization of an adnexal mass, CT is ‘Usually not appropriate’ because it exposes the patient to ionizing radiation and offers poorer soft-tissue characterization of the adnexa compared to ultrasound and MRI. However, if an adnexal mass is highly suspicious for advanced malignancy based on ultrasound or MRI, a CT of the chest, abdomen, and pelvis may be used for staging to look for metastatic disease, such as peritoneal carcinomatosis or distant metastases.

How should an adnexal mass in a pregnant patient be evaluated?

The evaluation should always begin with ultrasound. If the ultrasound is inconclusive and further characterization is necessary for maternal health, an MRI of the pelvis without intravenous contrast is the next appropriate step. Gadolinium-based contrast agents are generally avoided during pregnancy due to theoretical risks to the fetus and should only be used if the potential benefit to the mother is determined to be substantial.

What is the significance of a “simple” vs. “complex” cyst on ultrasound?

A “simple” cyst is a thin-walled, anechoic (black on ultrasound) fluid-filled structure with no internal septations or solid components. These are overwhelmingly benign, especially in premenopausal women. A “complex” cyst has features such as thick walls, septations, solid nodules, or internal debris. While many complex cysts are also benign (e.g., hemorrhagic cysts, endometriomas), these features raise the level of concern and may require further evaluation with follow-up ultrasound, MRI, or specialist consultation.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 26, 2026